Biomind Labs Announces Design of a Pharmaceutical Form for Psychedelic Drug Delivery Using 3D Printing
This advertisement has not loaded yet, but your article continues below. TORONTO — Biomind Labs Inc. (‘ Biomind
Global AI in Drug Discovery Market Industry: A Latest Research Report to Share Market Insights and Dynamics
AI in Drug Discovery Market is projected to grow up to 42.2% CAGR during the forecasting period 2021-2027. Artificial intelligence is the replica of human intelligence in machines which are designed to think like humans and mimic their activity. This
The Future of Transdermal and Microneedle Drug Delivery according to Ester Caffarel-Salvador, Associate Director, Regenerative Medicine, LEO Pharma A/S
SMi Reports: In preparation for the Inaugural Transdermal and Microneedle Drug Delivery Conference we hear from LEO Pharma
Dr. Ester Caffarel-Salvador is a multidisciplinary scientist with a background in biotechnology and biochemistry. She was recognized by the MIT technology review with
Did Europe blunder in its Covid vaccine picks? Pascal Soriot points to a potential mistake — and jabs back over delays
While Europe is in the midst of a massive fourth Covid-19 surge, the UK has largely avoided the high levels of hospitalizations and deaths seen on the rest of the continent. And AstraZeneca CEO Pascal…
House committee wants former FDA commissioner to come clean on Covid-related political interference
The House Select Subcommittee on the Coronavirus Crisis on Monday questioned former FDA commissioner Stephen Hahn on whether he acquiesced to political pressure in authorizing the use of…
J&J’s neuroscience renaissance? Janssen R&D chief readying for ‘golden age’
J&J’s Janssen neuroscience division has been a solid revenue contributor focused mostly on psychiatric drugs — but now its portfolio is headed for a change. Bill Martin, Janssen’s global head of…
$107B in 2+ years? Pfizer’s Covid-19 vaccine may redefine ‘megablockbuster’ by 2022 — analyst
If both its BioNTech-partnered Covid-19 vaccine and in-house antiviral live up to their full promises, Pfizer may be sitting on a $100 billion goldmine in 2022. That’s according to SVB Leerink analyst…
Covid-19 roundup: WHO looks to boost production of antibody tests in lower-income countries; US government fights to uphold workplace vaccine mandate
In an effort to combat rising Covid-19 cases worldwide, the World Health Organization has struck a deal to license serological technology for antibody testing and provide it royalty-free to low- and…
Vaccibody gets a new name and loads up with nearly $1B in biobucks for new vaccine pact with Regeneron
Vaccibody who? A little over a year after securing a $700 million-plus deal with Roche for its neoantigen cancer vaccine, the Norwegian biotech has attracted yet another Big Pharma partner with deep…
At busy Visp site, Lonza will up microbial services by 50%
In an effort to up its development of microbial-derived proteins, Swiss CDMO Lonza will invest in its manufacturing capacities in its home country. The extension will be good to go by the end of this…